Trial Profile
A Randomized, Placebo-controlled, Double-blind Trial to Assess Expanded Safety and Acceptability of Carraguard™ (PC-515) Vaginal Gel Among Heterosexual Couples in Chiang Rai
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Aug 2017
Price :
$35
*
At a glance
- Drugs PC 515 (Primary)
- Indications Balanitis; Candidiasis; Chlamydial infections; Gonorrhoea; HIV infections; Syphilis; Treponema infections; Vaginitis
- Focus Adverse reactions
- 05 Sep 2014 New trial record